Canadian Hematology Today

Articles

• 

  Mantle Cell Lymphoma: Evolving Frontline Treatment Strategies

  Inna Y. Gong, MD, John Kuruvilla, MD, Michael Crump, MD

  5–21

  • PDF (en)
  • PDF (fr)
• 

  Therapy for Myelodysplastic Syndromes Beyond the Front Line in 2024 in Canada

  Rena Buckstein, MD, FRCPC

  22–29

  • PDF (en)
  • PDF (fr)
• 

  Management of Chronic Myeloid Leukemia that is Intolerant or Resistant to Front-Line Treatment

  Lisa Bilston, MD, FRCPC, Kareem Jamani, MD, FRCPC

  31–39

  • PDF (en)
  • PDF (fr)
• 

  High-Risk Myeloma: Definitions and Treatments

  Rintu Sharma, MD, Karla Alexandra Sánchez Hernández, MD, Guido Lancman, MD, MSc

  41–47

  • PDF (en)
  • PDF (fr)
• 

  Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia After BTK Inhibitor and/or BCL-2 Inhibitor Failure

  Sue Robinson, MD, FRCPC

  49–53

  • PDF (en)
  • PDF (fr)